Adagene raises $50 mln

Adagene Inc said March 26 that it raised $50 million in series C funding led by Sequoia China. Also participating were New World TMT, AVIC Trust, King Star Capital, Gopher Asset Management as well as other investors. Adagene, of Suzhou, China, is an antibody discovery and development company.

27 March 2018•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail